Signalling and cellular heterogeneity in cancer - Marco Gerling, Leander Blaas, Rune Toftgård
Cancer is a complex disease.
Our group tackles tumor complexity from different angles, focusing on signaling pathways (Rune Toftgård), cellular heterogeneity (Leander Blaas) and cellular interactions (Marco Gerling) in cancer development and progression.
Menu
Hedghog signaling, tissue stem cells and cancer development
Hedghog signaling, tissue stem cells and cancer development
Rune Toftgård's group studies the role of Hedgehog signaling and tissue stem cells for cancer development.
Tumor-microenvironment interactions
Tumor-microenvironment interactions
Marco Gerling's group studies interactions between tumor cells and their microenvironment.
Cancer cells-of-origin and tumor heterogeneity
Cancer cells-of-origin and tumor heterogeneity
Leander Blaas' group studies the cells-of-origin and cellular heterogeneity of breast cancer.